![](https://images.squarespace-cdn.com/content/v1/54c68ac6e4b06d2e36a4b8c9/1585411667181-4DAUOCOD82BM712P2DRA/image-asset.jpeg)
LATEST NEWS IN PROSTATE CANCER
Provenge in 2012
Doctors finally seem to be comfortable with starting Provenge, a recently FDA approved immune therapy for prostate cancer. Dendreon, the manufacturer of Provenge, just reported a sharp uptick in their quarterly financials, indicating that the use of Provenge is increasing as doctors increase the amount of the drug they order.